However, the antigen expression pattern observed at relapse in B-ALL was consistent with CD19-22.BB.z-CAR delivering significant immune pressure on the CD19 antigen, whereas the lack of decrease or loss of CD22 expression suggests more limited immune pressure on the CD22 target. The gene discussed is CD22; the disease is precursor B-cell acute lymphoblastic leukemia.